Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 201–300 of 1,062
A Brief Historical Perspective on Dental Implants, Their Surface Coatings and Treatments
Abraham, C. M. (2014) · The Open Dentistry Journal · doi:10.2174/1874210601408010050 · Cited by 298
“Statins are prescribed medications used to decrease the liver synthesis of cholesterol [67].”
BackgroundThe Biochemistry and Molecular Biology of Isoprenoid Metabolism
Chappell, J. (1995) · Plant Physiology · doi:10.1104/pp.107.1.1 · Cited by 308
Trebicka, J., Hennenberg, M., Laleman, W., Shelest, N., Biecker, E., Schepke, M., Nevens, F., Sauerbruch, T., & Heller, J. (2007) · Hepatology · doi:10.1002/hep.21673 · Cited by 305
Sever, N., Song, B.-L., Yabe, D., Goldstein, J. L., Brown, M. S., & DeBose-Boyd, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310053200 · Cited by 304
Self-citationIsoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases
Inglese, J., Koch, W. J., Caron, M. G., & Lefkowitz, R. J. (1992) · Nature · doi:10.1038/359147a0 · Cited by 309
Regulation of caveolin and caveolae by cholesterol in MDCK cells
Hailstones, D., Sleer, L. S., Parton, R. G., & Stanley, K. K. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33898-0 · Cited by 309
Liao, J. K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.009 · Cited by 304
Regulation of HMG-CoA reductase in mammals and yeast
Burg, J. S., & Espenshade, P. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.07.002 · Cited by 303
“HMGR is also regulated at the level of translation by a non-sterol isoprenoid [10,53].”
InfluentialPheromone production in bark beetles
Blomquist, G. J., Figueroa-Teran, R., Aw, M., Song, M., Gorzalski, A., Abbott, N. L., Chang, E., & Tittiger, C. (2010) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2010.07.013 · Cited by 301
“Initial hormonal regulation may have been limited to entry or branch points in the pathway, analogously to the regulation of vertebrate cholesterol biosynthesis by HMGR (Goldstein and Brown, 1990).”
BackgroundPérez-Sala, D., Collado-Escobar, D., & Mollinedo, F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6235 · Cited by 303
Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.
Sheng, Z., Otani, H., Brown, M. S., & Goldstein, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.935 · Cited by 265
Self-citationCoppens, I., Sinai, A. P., & Joiner, K. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.1.167 · Cited by 304
“gondii (Table II), this would suggest an unusual pathway of cholesterol regulation (Goldstein and Brown, 1990).”
BackgroundTranslocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding.
Ridgway, N. D., Dawson, P. A., Ho, Y. K., Brown, M. S., & Goldstein, J. L. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.2.307 · Cited by 302
“Oxysterols regulate three events that are believed to take place in the ER, namely, repression of translation of HMG CoA reductase, acceleration of degradation of HMG The Journal of Cell Biology, Volume 116, 1992 CoA reductase, and activation of ACAT (Goldstein and Brown, 1990) .”
BackgroundSelf-citationEffects of statins and farnesyltransferase inhibitors on the development and progression of cancer
Graaf, M. R., Richel, D. J., van Noorden, C. J. F., & Guchelaar, H.-J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.06.010 · Cited by 300
X-Ray Structure of the hRORα LBD at 1.63 Å
Kallen, J. A., Schlaeppi, J.-M., Bitsch, F., Geisse, S., Geiser, M., Delhon, I., & Fournier, B. (2002) · Structure · doi:10.1016/s0969-2126(02)00912-7 · Cited by 298
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
“A second mechanism by which statins exert extrahepatic effects is their ability to prevent the synthesis of other important isoprenoid intermediates of the cholesterol biosynthetic pathway, such as farnesylpyrophosphate (FPP) and geranyl-geranylpyrophosphate (GGPP) that are downstream from L-mevalonic acid [11].”
BackgroundHua, X., Wu, J., Goldstein, J. L., Brown, M. S., & Hobbs, H. H. (1995) · Genomics · doi:10.1016/0888-7543(95)80009-b · Cited by 302
Self-citationAntioxidant Supplementation in the Treatment of Aging-Associated Diseases
Conti, V., Izzo, V., Corbi, G., Russomanno, G., Manzo, V., De Lise, F., Di Donato, A., & Filippelli, A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00024 · Cited by 304
“Treatment with CoQ10 resulted in a significant increase in total blood CoQ10 and reduced blood CoQ10, but did not translate into improved exercise performance or decreased oxidative stress (Bloomer et al., 2012).”
BackgroundInfluentialInhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298
“Statins, inhibiting HMG-CoA reductase activity, lower cholesterol by decreasing the production of low-density lipoproteins (LDL) and up-regulating the expression of LDL-receptor (Goldstein and Brown, 1990).”
BackgroundInfluentialImplant surface characteristics and their effect on osseointegration
Barfeie, A., Wilson, J., & Rees, J. (2015) · British Dental Journal · doi:10.1038/sj.bdj.2015.171 · Cited by 292
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Tsan, Y.-T., Lee, C.-H., Wang, J.-D., & Chen, P.-C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0917 · Cited by 294
Blanc, M., Hsieh, W. Y., Robertson, K. A., Watterson, S., Shui, G., Lacaze, P., Khondoker, M., Dickinson, P., Sing, G., Rodríguez-Martín, S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000598 · Cited by 301
“Inhibition of HMGCR is known to result in a reduction of the metabolic intermediate mevalonate (Figure 3) and an accompanying drop in cholesterol synthesis by the cell [49].”
Sanchez, H. B., Yieh, L., & Osborne, T. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1161 · Cited by 257
Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299
“Mevalonate is a precursor of two hydrophobic prenyl groups, farnesyl (15 carbons) and geranylgeranyl (20 carbons), which are attached to various cellular proteins, anchoring them to membranes (Goldstein and Brown, 1990).”
BackgroundSelf-citationAn update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
The Role of Statins in Cancer Therapy
Hindler, K., Cleeland, C. S., Rivera, E., & Collard, C. D. (2006) · The Oncologist · doi:10.1634/theoncologist.11-3-306 · Cited by 291
“Mevalonate is a precursor of several major products regulating the cell cycle, including dolichol, geranylpyrophosphate (GPP) and farnesylpyrophosphate (FPP) [ 3 ].”
BackgroundYoshida, H., & Kisugi, R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.038 · Cited by 288
The sterol-sensing domain: multiple families, a unique role?
Kuwabara, P. E., & Labouesse, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02640-9 · Cited by 290
Sugiyama, M., Kodama, T., Konishi, K., Abe, K., Asami, S., & Oikawa, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2697 · Cited by 285
Forman, B. M., Ruan, B., Chen, J., Schroepfer, G. J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10588 · Cited by 280
Song, B.-L., Javitt, N. B., & DeBose-Boyd, R. A. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.001 · Cited by 283
Exogenous influences on plant secondary metabolite levels
Pavarini, D. P., Pavarini, S. P., Niehues, M., & Lopes, N. P. (2012) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2012.07.002 · Cited by 273
Laufs, U., Gertz, K., Dirnagl, U., Böhm, M., Nickenig, G., & Endres, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02649-5 · Cited by 282
Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis
Lu, X.-Y., Shi, X.-J., Hu, A., Wang, J.-Q., Ding, Y., Jiang, W., Sun, M., Zhao, X., Luo, J., Qi, W., et al. (2020) · Nature · doi:10.1038/s41586-020-2928-y · Cited by 276
Nitta, M., Ku, S., Brown, C., Okamoto, A. Y., & Shan, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6660 · Cited by 283
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 278
A mouse model for Zellweger syndrome
Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P. E., Collen, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-49 · Cited by 275
Pharmacology of competitive inhibitors of HMg-CoA reductase
Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 277
Lane, K. T., & Beese, L. S. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600002-jlr200 · Cited by 280
“Also shown is the cholesterol biosynthesis pathway [adapted from (178)], from which the isoprenoid diphosphate substrates farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) are derived.”
Park, H.-J., Kong, D., Iruela-Arispe, L., Begley, U., Tang, D., & Galper, J. B. (2002) · Circulation Research · doi:10.1161/01.res.0000028149.15986.4c · Cited by 276
“Panels are as follows: 1, control; 2 and 3, cells infected with an adenovirus expressing a tetracycline-controlled transactivator (2) or a DN-RhoA (3); and 4, cells coinfected with adenoviruses expressing a transactivator and a DN-RhoA.”
BackgroundInfluentialOverlapping Functions of the Yeast Oxysterol-Binding Protein Homologues
Beh, C. T., Cool, L., Phillips, J., & Rine, J. (2001) · Genetics · doi:10.1093/genetics/157.3.1117 · Cited by 274
Statins and sepsis: multiple modifications at multiple levels
Terblanche, M., Almog, Y., Rosenson, R. S., Smith, T. S., & Hackam, D. G. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70111-1 · Cited by 271
Squalene – biochemistry, molecular biology, process biotechnology, and applications
Spanova, M., & Daum, G. (2011) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100203 · Cited by 268
“mostly in eubacteria and cyanobacteria, whereas MVA was found in archaea and a few eubacteria [41].”
BackgroundStatins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268
“This is also the ratelimiting step of cholesterol-synthesis, and is catalyzed by HMG- CoA reductase (Goldstein and Brown, 1990).”
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
Cox, A. D., & Der, C. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00011-5 · Cited by 266
Schnee, C., Köllner, T. G., Gershenzon, J., & Degenhardt, J. (2002) · Plant Physiology · doi:10.1104/pp.008326 · Cited by 269
Crowell, P. L., Chang, R. R., Ren, Z. B., Elson, C. E., & Gould, M. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47425-5 · Cited by 268
Isoprenoid Biosynthesis in Plants: Carbon Partitioning Within the Cytoplasmic Pathway
Newman, J. D., & Chappell, J. (1999) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239991209228 · Cited by 268
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Rudling, M., Norstedt, G., Olivecrona, H., Reihnér, E., Gustafsson, J. A., & Angelin, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6983 · Cited by 269
Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., & Yamamoto, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42151-x · Cited by 266
Ahn, K. S., Sethi, G., Krishnan, K., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610028200 · Cited by 264
Statins for children with familial hypercholesterolemia
Vuorio, A., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub4 · Cited by 265
Human Olfactory Receptors: Novel Cellular Functions Outside of the Nose
Maßberg, D., & Hatt, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00013.2017 · Cited by 262
Gong, Y., Lee, J. N., Lee, P. C. W., Goldstein, J. L., Brown, M. S., & Ye, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.014 · Cited by 262
“…in medium containing lipoprotein-deficient serum (LPDS), the sterol synthesis inhibitor compactin (an inhibitor of 3-hydroxy3-methylglutaryl coenzyme A reductase [HMG CoA reductase]), and a low concentration of mevalonate to prevent depletion of nonsterol endproducts (Goldstein and Brown, 1990).”
BackgroundMethodSelf-citationBeyond lipid lowering: the role of statins in vascular protection
Liao, J. K. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00195-x · Cited by 266
Laufs, U., Endres, M., Custodis, F., Gertz, K., Nickenig, G., Liao, J. K., & Böhm, M. (2000) · Circulation · doi:10.1161/01.cir.102.25.3104 · Cited by 265
Wilding, E. I., Brown, J. R., Bryant, A. P., Chalker, A. F., Holmes, D. J., Ingraham, K. A., Iordanescu, S., So, C. Y., Rosenberg, M., & Gwynn, M. N. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.15.4319-4327.2000 · Cited by 262
“The mevalonate pathway for IPP biosynthesis was first identified in eukaryotic cells (17).”
BackgroundBrain cholesterol turnover required for geranylgeraniol production and learning in mice
Kotti, T. J., Ramirez, D. M. O., Pfeiffer, B. E., Huber, K. M., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600316103 · Cited by 261
Grünler, J., Ericsson, J., & Dallner, G. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90200-3 · Cited by 261
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs, J. B., Pompliano, D. L., Mosser, S. D., Rands, E., Lingham, R. B., Singh, S. B., Scolnick, E. M., Kohl, N. E., & Oliff, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52998-7 · Cited by 260
Cellular metabolism regulates the differentiation and function of T-cell subsets
Ma, S., Ming, Y., Wu, J., & Cui, G. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01148-8 · Cited by 236
Review of progress in sterol oxidations: 1987–1995
Smith, L. L. (1996) · Lipids · doi:10.1007/bf02522641 · Cited by 258
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Xia, Y., Xie, Y., Yu, Z., Xiao, H., Jiang, G., Zhou, X., Yang, Y., Li, X., Zhao, M., Li, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.070 · Cited by 257
“Statins inhibit HMG-CoA reductase, an early stage enzyme in the MVA pathway (Goldstein and Brown, 1990).”
Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cells
Maeda, T., Matsunuma, A., Kurahashi, I., Yanagawa, T., Yoshida, H., & Horiuchi, N. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20074 · Cited by 256
SPHINGOLIPID FUNCTIONS IN SACCHAROMYCES CEREVISIAE: Comparison to Mammals
Dickson, R. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.27 · Cited by 253
Scalcinati, G., Knuf, C., Partow, S., Chen, Y., Maury, J., Schalk, M., Daviet, L., Nielsen, J., & Siewers, V. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.01.007 · Cited by 251
“, 1998) and its intracellular concentration is tightly regulated at different levels (Goldstein and Brown, 1990).”
BackgroundA role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism
Atamna, H., & Frey, W. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404349101 · Cited by 252
Mancini, G. B. J., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D., Pearson, G. J., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.003 · Cited by 250
Barrier function regulates epidermal DNA synthesis.
Proksch, E., Feingold, K. R., Man, M. Q., & Elias, P. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115183 · Cited by 252
Bist, A., Fielding, P. E., & Fielding, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10693 · Cited by 253
Schrick, K., Mayer, U., Horrichs, A., Kuhnt, C., Bellini, C., Dangl, J., Schmidt, J., & Jürgens, G. (2000) · Genes & Development · doi:10.1101/gad.14.12.1471 · Cited by 249
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP‐activated protein kinase
Henin, N., Vincent, M. ‐., Gruber, H. E., & Van Den Berghe, G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737463 · Cited by 251
“The nearcomplete inhibition of cholesterol synthesis under this condition is most likely explained by utilization of the small amounts of mevalonate still produced for the synthesis of nonsterol end products ( 2 ).”
BackgroundLovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal, B., Bhendwal, S., Halmos, B., Moss, S. F., Ramey, W. G., & Holt, P. R. (1999) · PubMed · Cited by 251
Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model
Kim, S., Sohn, I., Ahn, J.-I., Lee, K.-H., Lee, Y. S., & Lee, Y. S. (2004) · Gene · doi:10.1016/j.gene.2004.06.015 · Cited by 248
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
Cafforio, P., Dammacco, F., Gernone, A., & Silvestris, F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi036 · Cited by 250
Gene family for an elicitor-induced sesquiterpene cyclase in tobacco.
Facchini, P. J., & Chappell, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11088 · Cited by 251
In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products
Diomede, L., Albani, D., Sottocorno, M., Donati, M. B., Bianchi, M., Fruscella, P., & Salmona, M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.094222 · Cited by 246
Steady-state kinetic mechanism of ras farnesyl:protein transferase
Pompliano, D. L., Rands, E., Schaber, M. D., Mosser, S. D., Anthony, N. J., & Gibbs, J. B. (1992) · Biochemistry · doi:10.1021/bi00130a010 · Cited by 246
The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways
Boucher, Y., & Doolittle, W. F. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02004.x · Cited by 249
“Animals Sterols Membrane stabilizers, steroid hormones and bile acids precursors in vertebrates Rohmer (1999) Goldstein and Brown (1990) Ubiquinone Quinones of electron transport chains Dolichols Carbohydrate carriers LGT and IPP biosynthesis pathway evolution 705”
BackgroundInfluentialImpaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y.-I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 248
“rate-limiting enzyme for cholesterol biosynthesis (29).”
Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol
Lange, Y., Ye, J., Rigney, M., & Steck, T. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32101-5 · Cited by 248
Terpene Specialized Metabolism in Arabidopsis thaliana
Tholl, D., & Lee, S. (2011) · The Arabidopsis Book · doi:10.1199/tab.0143 · Cited by 244
IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradation
Sun, S., Shi, G., Sha, H., Ji, Y., Han, X., Shu, X., Ma, H., Inoue, T., Gao, B., Kim, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3266 · Cited by 253
“Similar to the case of HMG-CoA reductase (HMGCR) where its degradation is high responsive to host physiology 3,34 , our data demonstrate that IRE1 α degradation by ERAD is highly responsive to ER homeostasis (Fig.”
Biosynthesis and Function of Modified Nucleosides
Björk, G. R. (2014) · tRNA · doi:10.1128/9781555818333.ch11 · Cited by 244
Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression.
Amri, E., Bertrand, B., Ailhaud, G., & Grimaldi, P. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41912-1 · Cited by 244
DeBose-Boyd, R. A., Ou, J., Goldstein, J. L., & Brown, M. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1477 · Cited by 209
Self-citationThe vulnerable atherosclerotic plaque
Aikawa, M., & Libby, P. (2004) · Cardiovascular Pathology · doi:10.1016/s1054-8807(04)00004-3 · Cited by 243
“Statins suppress cholesterol biosynthesis by inhibiting its ratelimiting enzyme, an HMG-CoA reductase, and decrease not only cholesterol but also intermediate isoprenoid metabolites, including farnesylpyrophosphate and geranylgeranylpyrophosphate [96].”
BackgroundSelemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. H. W., & Drummond, G. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.005 · Cited by 242
Integration of mass spectrometry in analytical biotechnology
Carr, S. A., Hemling, M. E., Bean, M. F., & Roberts, G. D. (1991) · Analytical Chemistry · doi:10.1021/ac00024a003 · Cited by 241
Targeting tumor cell metabolism with statins
Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 239
Rodríguez-Concepción, M. (2006) · Phytochemistry Reviews · doi:10.1007/s11101-005-3130-4 · Cited by 241
“The MVA pathway, which provides the precursors for the biosynthesis of cholesterol and the prenylation of Ras proteins in animals, has been extensively studied since its discovery in the 1950s (Goldstein and Brown, 1990).”
BackgroundSheldon, I. M., Cronin, J. G., & Bromfield, J. J. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115227 · Cited by 228
“About 90% of the cholesterol in cells is contained within the plasma membrane, and cholesterol concentrations are tightly regulated by cholesterol uptake, cholesterol efflux transporters, and by cholesterol synthesis (87).”
Estévez, J. M., Cantero, A., Romero, C., Kawaide, H., Jiménez, L. F., Kuzuyama, T., Seto, H., Kamiya, Y., & León, P. (2000) · Plant Physiology · doi:10.1104/pp.124.1.95 · Cited by 240
“For a long time it was assumed that IPP was synthesized exclusively by the mevalonate pathway in all organisms (Spurgeon and Porter, 1981; Goldstein and Brown, 1990).”
BackgroundMicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels
Goedeke, L., Rotllan, N., Canfrán-Duque, A., Aranda, J. F., Ramírez, C. M., Araldi, E., Lin, C.-S., Anderson, N. N., Wagschal, A., de Cabo, R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3949 · Cited by 238
“While SREBP1c is regulated by insulin, oxysterols, and phosphatidylcholine and preferentially enhances the transcription of genes involved in fatty acid, phospholipid and triacylglycerol synthesis, SREBP2 and SREBP1a are regulated by intracellular cholesterol concentrations 3,8,9 .”
Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol
Burke, Y. D., Stark, M. J., Roach, S. L., Sen, S. E., & Crowell, P. L. (1997) · Lipids · doi:10.1007/s11745-997-0019-y · Cited by 239
“Geraniol, farnesol, and geranylgeraniol (Scheme 1) are the alcohol metabolites of the corresponding pyrophosphates (5,6) which are key intermediates in the mevalonate pathway of both plants and mammals (7).”
BackgroundMcGirt, M. J., Lynch, J. R., Parra, A., Sheng, H., Pearlstein, R. D., Laskowitz, D. T., Pelligrino, D. A., & Warner, D. S. (2002) · Stroke · doi:10.1161/01.str.0000038986.68044.39 · Cited by 239
Molecular mechanisms of action of bisphosphonates
Rogers, M. J., Frith, J. C., Luckman, S. P., Coxon, F. P., Benford, H. L., M̈onkk̈onen, J., Auriola, S., Chilton, K. M., & Russell, R. G. G. (1999) · Bone · doi:10.1016/s8756-3282(99)00070-8 · Cited by 237
Worman, H. J., Evans, C. D., & Blobel, G. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.4.1535 · Cited by 235
“Besides functioning as membrane transport proteins, polytopic integral membrane proteins have also been shown to function in signal transduction mediated by GTP-binding proteins (11) and as the enzyme catalyzing the rate-limiting reaction of cholesterol biosynthesis (21, 29).”
BackgroundEvidence for a Niemann–Pick C (NPC) Gene Family: Identification and Characterization of NPC1L1
Davies, J. P., Levy, B., & Ioannou, Y. A. (2000) · Genomics · doi:10.1006/geno.2000.6151 · Cited by 238
Danesh, F. R., Sadeghi, M. M., Amro, N., Philips, C., Zeng, L., Lin, S., Sahai, A., & Kanwar, Y. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122228799 · Cited by 233
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.